Alıravcı, I. D., Mutlu, P., Oymak, S., Guney, U. I., & Keskin, O. (2025). Risk of Latent Tuberculosis Infection Reactivation in Patients Treated with Tumor Necrosis Factor Antagonists: A Five-Year Retrospective Study. MDPI AG.
Chicago Style (17th ed.) CitationAlıravcı, Işıl Deniz, Pınar Mutlu, Sibel Oymak, Ufuk Ilter Guney, and Oguzhan Keskin. Risk of Latent Tuberculosis Infection Reactivation in Patients Treated with Tumor Necrosis Factor Antagonists: A Five-Year Retrospective Study. MDPI AG, 2025.
MLA (9th ed.) CitationAlıravcı, Işıl Deniz, et al. Risk of Latent Tuberculosis Infection Reactivation in Patients Treated with Tumor Necrosis Factor Antagonists: A Five-Year Retrospective Study. MDPI AG, 2025.
Warning: These citations may not always be 100% accurate.